Evidence map›Paper›PMID 18006877›Full record

ArticleAmerican journal of respiratory cell and molecular biology2008

Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.

Hitesh S Deshmukh, Colleen Shaver, Lisa M Case, Maggie Dietsch, Scott C Wesselkamper, William D Hardie, Thomas R Korfhagen, Massimo Corradi, Jay A Nadel, Michael T Borchers and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 119 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. E-cigarette aerosols of propylene glycol impair BK channel activity and parameters of mucociliary function.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Alternative Oxidase Attenuates Cigarette Smoke-induced Lung Dysfunction and Tissue Damage.American journal of respiratory cell and molecular biology · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Hitesh S DeshmukhCenter for Environmental Genetics, University of Cincinnati, Cincinnati, USA.
Colleen Shaver
Lisa M Case
Maggie Dietsch
Scott C Wesselkamper
William D Hardie
Thomas R Korfhagen
Massimo Corradi
Jay A Nadel
Michael T Borchers
George D Leikauf
University of Cincinnati · USCincinnati Children's Hospital Medical Center · USUniversity of California, San Francisco · USUniversity of Parma · ITUniversity of Pittsburgh · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injuryU01ES015675 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEIKAUF, GEORGE DOUGLAS · 2006 to 2020
$8.9M
GENETIC DETERMINATION OF ACUTE LUNG INJURYR01HL065612 · NHLBI · UNIVERSITY OF CINCINNATI · PI LEIKAUF, GEORGE DOUGLAS · 2000 to 2004
$1.5M
Novel Biomarkers of COPD - Parma SiteR01HL072323 · NHLBI · UNIVERSITY OF PARMA · PI MUTTI, ANTONIO · 2002 to 2005
$1.5M
Growth Factor Protection in Acute Lung InjuryR01HL077763 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEIKAUF, GEORGE DOUGLAS · 2006 to 2009
$1.4M
Role of Metalloproteinases in Mucin Overproduction in COPDR01HL085655 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEIKAUF, GEORGE DOUGLAS · 2008 to 2011
$1.4M
NHLBI NIH HHS HL065612NHLBI NIH HHS HL072323NHLBI NIH HHS HL077763NHLBI NIH HHS HL085655NIEHS NIH HHS ES006096NIEHS NIH HHS ES015675NIEHS NIH HHS U01 ES015675
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD), a global public health problem, is characterized by progressive difficulty in breathing, with increased mucin production, especially in the small airways. Acrolein, a constituent of cigarette smoke and an endogenous mediator of oxidative stress, increases airway mucin 5, subtypes A and C (MUC5AC) production; however, the mechanism remains unclear. In this study, increased mMUC5AC transcripts and protein were associated with increased lung matrix metalloproteinase 9 (mMMP9) transcripts, protein, and activity in acrolein-exposed mice. Increased mMUC5AC transcripts and mucin protein were diminished in gene-targeted Mmp9 mice [Mmp9((-/-))] or in mice treated with an epidermal growth factor receptor (EGFR) inhibitor, erlotinib. Acrolein also decreased mTissue inhibitor of metalloproteinase protein 3 (an MMP9 inhibitor) transcript levels. In a cell-free system, acrolein increased pro-hMMP9 cleavage and activity in concentrations (100-300 nM) found in sputum from subjects with COPD. Acrolein increased hMMP9 transcripts in human airway cells, which was inhibited by an MMP inhibitor, EGFR-neutralizing antibody, or a mitogen-activated protein kinase (MAPK) 3/2 inhibitor. Together these findings indicate that acrolein can initiate cleavage of pro-hMMP9 and EGFR/MAPK signaling that leads to additional MMP9 formation. Augmentation of hMMP9 activity, in turn, could contribute to persistent excessive mucin production.

Indexed as

AcroleinAnimalsEnzyme ActivationErbB ReceptorsGene Expression Regulation, EnzymologicHumansLungMaleMAP Kinase Signaling SystemMatrix Metalloproteinase 9MiceMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mucin 5ACMucinsPulmonary Disease, Chronic ObstructiveAcroleinErbB ReceptorsMatrix Metalloproteinase 9Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3MUC5AC protein, humanMuc5ac protein, mouseMucin 5ACMucinsRNA, MessengerTissue Inhibitor of Metalloproteinase-3

Identifiers

PMID18006877
PMCPMC2274947
OpenAlexW2051278731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.